Pfizer Settles Biohaven Kickback Suit for Nearly $60M

Pfizer Settles Biohaven Kickback Suit for Nearly $60M

Source: 
BioSpace
snippet: 

From March 2020 through September 2022, Biohaven wielded meals at high-end restaurants and paid speaking opportunities to induce healthcare providers to prescribe its migraine therapy Nurtec ODT, according to the Department of Justice.